Ethmozine

Active Ingredient(s): Moricizine
FDA Approved: * June 19, 1990
Pharm Company: * SHIRE
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ethmozine Overview

Moracizine[1] or moricizine, sold under the trade name Ethmozine, is an antiarrhythmic of class IC.[2] It was used for the prophylaxis and treatment of serious and life-threatening ventricular arrhythmias,[3] but was withdrawn in 2007 for commercial reasons.[4] Pharmacology Moracizine, a phenothiazine derivative, undergoes extensive first-pass metabolism and is also extensively metabolized after it has entered the circulation....

Read more Ethmozine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Moracizine

Recent Ethmozine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Moricizine
  • Tablet: 200mg, 250mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ethmozine: (3 results)

Sorted by National Drug Code
  • 54092-046 Ethmozine 200 mg Oral Tablet by Shire Us Inc.
  • 54092-047 Ethmozine 250 mg Oral Tablet by Shire Us Inc.
  • 54092-048 Ethmozine 300 mg Oral Tablet by Shire Us Inc.

Other drugs which contain Moricizine or a similar ingredient: (1 result)

Related Ethmozine Topics:

Ethmozine(Moricizine)
Do you have Ethmozine on market as generic drug yet?I am interested because of the high cost of the drug ## please notif... 1 reply
is there any more ethmozine out there?
My mother in law needs ethmozine, but she only has a 2 week supply. She cannot tolerate the alternative medications. Doe...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA